dc.contributor.author | Koyuncu, H | |
dc.contributor.author | Baykut, F | |
dc.contributor.author | Soybir, G | |
dc.contributor.author | Berkarda, B | |
dc.date.accessioned | 2021-03-06T10:39:02Z | |
dc.date.available | 2021-03-06T10:39:02Z | |
dc.date.issued | 1998 | |
dc.identifier.citation | Berkarda B., Koyuncu H., Soybir G., Baykut F., "Inhibitory effect of Hesperidin on tumour initiation and promotion in mouse skin", RESEARCH IN EXPERIMENTAL MEDICINE, cilt.198, ss.93-99, 1998 | |
dc.identifier.issn | 0300-9130 | |
dc.identifier.other | av_eb630170-50a1-413a-a458-ffa016c986eb | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/154582 | |
dc.identifier.uri | https://doi.org/10.1007/s004330050093 | |
dc.description.abstract | A flavonoid, Hesperidin was evaluated for its ability to inhibit tumour initiation by a polycyclic aromatic hydrocarbon and tumour promotion by a phorbol ester in the skin of CD-1 mice. Subcutaneous application of Hesperidin did not inhibit 7,12-dimethylbenz(a)anthracene-induced tumour initiation but did inhibit 12-O-tetradecanoyl-13-phorbol acetate-induced tumour promotion. Results provide evidence for a potential chemopreventive activity of Hesperidin. | |
dc.language.iso | eng | |
dc.subject | Tıbbi Ekoloji ve Hidroklimatoloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | TIP, ARAŞTIRMA VE DENEYSEL | |
dc.title | Inhibitory effect of Hesperidin on tumour initiation and promotion in mouse skin | |
dc.type | Makale | |
dc.relation.journal | RESEARCH IN EXPERIMENTAL MEDICINE | |
dc.contributor.department | , , | |
dc.identifier.volume | 198 | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 93 | |
dc.identifier.endpage | 99 | |
dc.contributor.firstauthorID | 121234 | |